Cardiac Safety Services Market by Service Type (Blood Pressure Measurement Services, Cardiovascular Imaging Services, ECG or Holter Measurement Services), Type (Integrated Services, Standalone Services), End-User - Global Forecast 2024-2030
Cardiac Safety Services Market by Service Type (Blood Pressure Measurement Services, Cardiovascular Imaging Services, ECG or Holter Measurement Services), Type (Integrated Services, Standalone Services), End-User - Global Forecast 2024-2030
The Cardiac Safety Services Market size was estimated at USD 1.22 billion in 2023 and expected to reach USD 1.34 billion in 2024, at a CAGR 10.91% to reach USD 2.52 billion by 2030.
Cardiac safety services provide services, solutions, and technologies for evaluating the safety of medical devices, drugs, and interventions concerning their potential effects on cardiac health. These services encompass various applications, including preclinical testing, clinical trials, post-marketing surveillance, and risk management for pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers. The surge in the prevalence of cardiovascular diseases worldwide and the growing focus on personalized medicine is propelling the need for early diagnosis and accurate risk assessments for cardiac. Stringent regulations imposed by health authorities necessitate a detailed evaluation of potential side effects on cardiac function before marketing approval for drugs and medical devices. However, high costs associated with comprehensive cardiovascular risk assessment procedures may limit their adoption, particularly in resource-limited settings or smaller organizations without extensive research and development (R&D) budgets.
Regional Insights
The cardiac safety services market is witnessing significant growth in the Americas owing to the increasing prevalence of cardiovascular diseases, higher healthcare expenditures, and advancements in diagnostic technologies. Investments in research and development have resulted in several new patents, such as noninvasive blood pressure monitoring algorithms and cardiac biomarker detection methods in the Americas. In the European Union (EU), regulatory authorities' stringent measures have led to increased demand for cardiac safety services. The EMEA region is investing heavily in improving healthcare infrastructure and attracting international investments for specialized medical services such as cardiac safety services. The APAC region boasts a rapidly expanding market for cardiac safety services driven by an aging population and increasing cardiovascular disease incidence, and the government supports the development of innovative technologies through investments in research. Additionally, pharmaceutical companies are increasingly investing in research to develop cost-effective cardiac monitoring solutions, which are expected to boost their use by end-users worldwide.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Cardiac Safety Services Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Rising incidence of cardiovascular disorders and the need for effective & safe treatment
Use of biosimilars and biomarkers to detect cardiotoxicity or cardiovascular risks
Government initiatives encouraging personalized treatments in cardiology
Market Restraints
Relatively high cost of cardiac evaluation services and limited availability of skilled professionals
Market Opportunities
Advancements in cardiac safety testing and monitoring systems
Growing number of clinical trials and R&D for cardiac treatments
Market Challenges
Lack of regulatory standardization across various countries
Market Segmentation Analysis
Service Type: Proliferating need for efficient cardiovascular imaging services
Type: Expanding use of integrated cardiac safety services for drug development
End-User: Surging adoption of cardiac safety services by pharmaceutical & biopharmaceutical companies
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cardiac Safety Services Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cardiac Safety Services Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
OSF HealthCare Establishes a Partnership with Bellin Health to Expand Cardiovascular Services in Delta County
OSF Cardiovascular Care collaborated with Bellin Health to launch a new cardiology clinic within OSF Medical Group - Escanaba. This cutting-edge facility has a state-of-the-art cardiac catheterization lab overseen by the esteemed Bellin Health cardiovascular team and is tentatively scheduled to open in winter 2024. Patients benefit from enhanced accessibility to a wide range of tests and procedures, eliminating the need for extensive travel and long appointment wait times.
Jubilant Radiopharma and Cardiac Imaging, Inc. Announce Exclusive Partnership to Expand Access for Mobile Cardiac PET Offering
Jubilant DraxImage Inc., a subsidiary of Jubilant Pharma Limited, partnered with Cardiac Imaging, Inc. to offer a daily-leased rubidium solution for cardiac PET testing. This collaboration allows healthcare facilities to choose between the flexible daily-leasing program for the RUBY Rubidium Elution System and RUBY-FILL (Rubidium Rb82 generator), or establish a full-time PET program.
GE HealthCare Announces Vscan Air SL Device for Cardiac, Vascular Patients
GE Healthcare introduced the Vscan Air SL, a handheld and wireless ultrasound imaging system specifically designed for cardiac and vascular assessments at the point of care. This innovative device incorporates GE Healthcare's advanced SignalMax and XDclear technology, which ensures significant imaging performance with high levels of penetration, resolution, and sensitivity,
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cardiac Safety Services Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Cardiac Safety Services Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AliveCor, Inc., Banook Group, Biotrial, Butterfly Network Inc., Celerion, Certara, Inc., Circle Cardiovascular Imaging Inc., Clario, Clyde Biosciences Limited, Dozee, Eurofins Scientific SE, GE HealthCare Technologies Inc., ICON PLC, IQVIA Holdings Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Lunit Inc., Medpace, Inc., MERIT CRO, Inc., Metrion Biosciences Limited, Ncardia Services B.V., NEXEL Co., Ltd., Octagos Health, Inc., PhysioStim SAS, Richmond Pharmacology Limited, Shanghai Medicilon Inc., Siemens Healthcare GmbH, Tempus Labs, Inc., Thermo Fisher Scientific Inc., and Toray Medical Company Limited by Toray Industries.
Market Segmentation & Coverage
This research report categorizes the Cardiac Safety Services Market to forecast the revenues and analyze trends in each of the following sub-markets:
Service Type
Blood Pressure Measurement Services
Cardiovascular Imaging Services
ECG or Holter Measurement Services
Thorough QT Studies
Type
Integrated Services
Standalone Services
End-User
Contract Research Organizations
Pharmaceutical & Biopharmaceutical Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of cardiovascular disorders and the need for effective & safe treatment
5.1.1.2. Use of biosimilars and biomarkers to detect cardiotoxicity or cardiovascular risks
5.1.1.3. Government initiatives encouraging personalized treatments in cardiology
5.1.2. Restraints
5.1.2.1. Relatively high cost of cardiac evaluation services and limited availability of skilled professionals
5.1.3. Opportunities
5.1.3.1. Advancements in cardiac safety testing and monitoring systems
5.1.3.2. Growing number of clinical trials and R&D for cardiac treatments
5.1.4. Challenges
5.1.4.1. Lack of regulatory standardization across various countries
5.2. Market Segmentation Analysis
5.2.1. Service Type: Proliferating need for efficient cardiovascular imaging services
5.2.2. Type: Expanding use of integrated cardiac safety services for drug development
5.2.3. End-User: Surging adoption of cardiac safety services by pharmaceutical & biopharmaceutical companies
5.3. Market Trend Analysis
5.3.1. Highly advanced healthcare infrastructure and presence of established vendors favored by supportive regulatory landscape in the Americas
5.3.2. Potential of the Asia-Pacific to be a preferred arena for cardiology trials and expanding adoption cardiovascular disease treatment
5.3.3. Well-defined regulatory standards surrounding cardiac safety in Europe and the rise of the Middle East & Africa as a potential clinical trial hub
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
5.8. Client Customization
6. Cardiac Safety Services Market, by Service Type
6.1. Introduction
6.2. Blood Pressure Measurement Services
6.3. Cardiovascular Imaging Services
6.4. ECG or Holter Measurement Services
6.5. Thorough QT Studies
7. Cardiac Safety Services Market, by Type
7.1. Introduction
7.2. Integrated Services
7.3. Standalone Services
8. Cardiac Safety Services Market, by End-User
8.1. Introduction
8.2. Contract Research Organizations
8.3. Pharmaceutical & Biopharmaceutical Companies
9. Americas Cardiac Safety Services Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cardiac Safety Services Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cardiac Safety Services Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. OSF HealthCare Establishes a Partnership with Bellin Health to Expand Cardiovascular Services in Delta County
12.3.2. Jubilant Radiopharma and Cardiac Imaging, Inc. Announce Exclusive Partnership to Expand Access for Mobile Cardiac PET Offering
12.3.3. GE HealthCare Announces Vscan Air SL Device for Cardiac, Vascular Patients
12.3.4. Clario and AliveCor Collaborate to Offer Advanced, Trial-Focused Six-Lead ECG Solutions for Monitoring in Decentralized Clinical Trials
12.3.5. Metrion Biosciences Announces Launch of Good Laboratory Practice (GLP) hERG Screening Service
12.3.7. AliveCor, Luscii Partner On ‘Heart Clinic In a Box’
12.3.8. Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker
12.3.9. Philips, Biotronik Partner to Expand Care for Out-of-Hospital Cardiology Labs
12.3.10. Abbott Completes USD 890 Million Acquisition of Cardiovascular Systems
12.3.11. Philips and TriHealth Announce Multi-Year Partnership at Heart of New Trihealth Heart & Vascular Institute on the Campus of Bethesda North Hospital
12.3.12. Banook Group Continues Global Expansion with the U.S. Office Opening